Scinai Immunotherapeutics annual ebitda
2021
2022
2023
2024
2025
Scinai Immunotherapeutics EBITDA Growth & History (SCNI)
Scinai Immunotherapeutics's calculated EBITDA was −$6.1M for fiscal 2025.
View full Scinai Immunotherapeutics company overviewScinai Immunotherapeutics annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$6.1M | $868,000 | — |
| 2024 | 2024-12-31 | −$7.0M | $2.2M | — |
| 2023 | 2023-12-31 | −$9.2M | $1.3M | — |
| 2022 | 2022-12-31 | −$10.5M | −$108,000 | — |
| 2021 | 2021-12-31 | −$10.4M | — | — |
Scinai Immunotherapeutics quarterly ebitda
Q1.22
Q2.22
Q1.23
Q2.23
Q4.24
Q1.25
Q2.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $4.8M | $6.7M | — |
| Q1 2026 | 2026-03-31 | −$2.0M | −$797,000 | — |
| Q2 2025 | 2025-06-30 | −$1.8M | — | — |
| Q1 2025 | 2025-03-31 | −$1.2M | — | — |
| Q4 2024 | 2024-12-31 | −$1.7M | — | — |
| Q2 2023 | 2023-06-30 | −$2.4M | $670,000 | — |
| Q1 2023 | 2023-03-31 | −$3.0M | −$567,000 | — |
| Q2 2022 | 2022-06-30 | −$3.1M | — | — |
| Q1 2022 | 2022-03-31 | −$2.5M | — | — |
Scinai Immunotherapeutics ebitda trends
Between the periods ended 2021-12-31 and 2025-12-31, Scinai Immunotherapeutics's ebitda increased from −$10.4M to −$6.1M, a change of $4.3M. The latest reported quarter, Q2 2026, shows $4.8M.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Scinai Immunotherapeutics source filings ↗